Trojan Rugira

Trojan Rugira is a Research Fellow in the Department of Internal Medicine at Yale School of Medicine. His research focuses on genetic and molecular mechanisms underlying hypertension and cancer biology, with a particular emphasis on PRDM6 regulation in renal development and radiotherapy resistance pathways in breast cancer. He employs systems biology approaches to uncover disease mechanisms and explores natural product-based anticancer therapies.

Key research interests include hypertension pathophysiology, tumor metastasis, and drug resistance. His work integrates clinical observations with molecular biology techniques to identify therapeutic targets. Recent publications highlight contributions to understanding PRDM6's role in renin-producing cells, HIF-1α-driven metastatic niche formation, and STAT-3 pathway inhibition by cardiac glycosides.

Rugira's multidisciplinary approach bridges basic science and clinical applications, aiming to translate discoveries into improved patient care. Current investigations include systems-level analysis of hypertension genetics and developing novel strategies to combat radiotherapy-resistant cancers.